Pharsight

Adamas Operations patents expiration

1. Gocovri patents expiration

GOCOVRI's oppositions filed in EPO
Can you believe GOCOVRI received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8895614 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8889740 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8895617 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8895616 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8895618 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8796337 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8895615 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8389578 ADAMAS OPERATIONS Composition and method for treating neurological disease
Jan, 2028

(3 years from now)

US11197835 ADAMAS OPERATIONS Method of administering amantadine prior to a sleep period
Dec, 2030

(6 years from now)

US9877933 ADAMAS OPERATIONS Method of administering amantadine prior to a sleep period
Dec, 2030

(6 years from now)

US9867791 ADAMAS OPERATIONS Method of administering amantadine prior to a sleep period
Dec, 2030

(6 years from now)

US8741343 ADAMAS OPERATIONS Method of administering amantadine prior to a sleep period
Dec, 2030

(6 years from now)

US9867792 ADAMAS OPERATIONS Method of administering amantadine prior to a sleep period
Dec, 2030

(6 years from now)

US9867793 ADAMAS OPERATIONS Method of administering amantadine prior to a sleep period
Dec, 2030

(6 years from now)

US10646456 ADAMAS OPERATIONS Methods of administering amantadine
Jun, 2034

(10 years from now)

US10154971 ADAMAS OPERATIONS Methods of administering amantadine
Dec, 2034

(10 years from now)

US11077073 ADAMAS OPERATIONS Methods of using amantadine compositions
Aug, 2038

(14 years from now)

US11065213 ADAMAS OPERATIONS Amantadine compositions and preparations thereof
Aug, 2038

(14 years from now)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-153) Aug 24, 2024
Orphan Drug Exclusivity(ODE) Aug 24, 2024
New Indication(I-769) Aug 24, 2020
New Product(NP) Aug 24, 2020

Drugs and Companies using AMANTADINE HYDROCHLORIDE ingredient

Market Authorisation Date: 24 August, 2017

Treatment: Treatment of dyskinesia in patients with parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications; Treatment of dyskinesia in patients with parkinson'...

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

How can I launch a generic of GOCOVRI before it's drug patent expiration?
More Information on Dosage

GOCOVRI family patents

Family Patents

2. Osmolex Er patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
USRE39069 ADAMAS OPERATIONS Multi-layered osmotic device
May, 2018

(5 years ago)

US8895614 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8895618 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8987333 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8895616 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8889740 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US9072697 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8895615 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8895617 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8796337 ADAMAS OPERATIONS Composition and method for treating neurological disease
Nov, 2025

(1 year, 7 months from now)

US8574626 ADAMAS OPERATIONS Osmotic device containing amantadine and an osmotic salt
Nov, 2025

(1 year, 7 months from now)

US8389578 ADAMAS OPERATIONS Composition and method for treating neurological disease
Jan, 2028

(3 years from now)

US8252331 ADAMAS OPERATIONS Osmotic device containing amantadine and an osmotic salt
Mar, 2030

(5 years from now)

US10500170 ADAMAS OPERATIONS Composition and method for treating neurological disease
Feb, 2038

(13 years from now)

US10500172 ADAMAS OPERATIONS Composition and method for treating neurological disease
Feb, 2038

(13 years from now)

US10512617 ADAMAS OPERATIONS Composition and method for treating neurological disease
Feb, 2038

(13 years from now)

US10213393 ADAMAS OPERATIONS Composition and method for treating neurological disease
Feb, 2038

(13 years from now)

US10213394 ADAMAS OPERATIONS Composition and method for treating neurological disease
Feb, 2038

(13 years from now)

US10500171 ADAMAS OPERATIONS Composition and method for treating neurological disease
Feb, 2038

(13 years from now)

Drugs and Companies using AMANTADINE HYDROCHLORIDE ingredient

Market Authorisation Date: 16 February, 2018

Treatment: Treatment of drug-induced extrapyramidal reactions in adult patients with parkinson's disease; Treatment of drug-induced extrapyramidal reaction in adult patients; A process for treating a patient suf...

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

OSMOLEX ER family patents

Family Patents